Listed

RTW INVESTMENTS, LP

An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1493215.

Share

Holdings: 84 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

RTW INVESTMENTS, LP, holdings
IssuerClassCUSIPReported value$mWeightSharesPut or callChange on the quarter before
Madrigal Pharmaceuticals IncMDGLCOM5588681051,0719.1%1,993,687Unchanged
Argenx SEARGXSPONSORED ADR04016X1016585.6%709,446Unchanged
PTC Therapeutics IncPTCTCOM69366J2006325.4%7,746,415Unchanged
Protagonist Therapeutics IncPTGXCOM74366E1026205.3%5,061,175Added+2,122
CG Oncology IncCGONCOM1569441006055.2%8,514,590Added+1,529,782
Insmed IncINSMCOM PAR $.014576693075164.4%4,842,880Unchanged
Tango Therapeutics IncTNGXCOM87583X1094353.7%13,900,620Added+600,000
Spyre Therapeutics IncSYRECOM NEW00773J2023773.2%4,251,996Added+80,000
Celcuity IncCELCCOM15102K1003463.0%3,304,903Added+265,282
Erasca IncERASCOM29479A1083292.8%17,946,754Added+1,789,579
Radnet IncRDNTCOM7504911022992.6%4,846,958Added+561,958
Oruka Therapeutics IncORKACOM6876041082992.6%3,139,030Added+1,080,882
Natera IncNTRACOM6323071042712.3%1,000,000Reduced−250,000
Ultragenyx Pharmaceutical inRARECOM90400D1082602.2%7,796,895Added+4,148,100
Irhythm Holdings IncIRTCCOM4500561062602.2%2,182,631Added+514,131
Cytokinetics IncCYTKCOM NEW23282W6052442.1%2,862,003Added+140,845
Kailera Therapeutics IncKLRACOMMON STOCK4829311022372.0%10,776,820New+10,776,820
Establishment Labs Holdings IncCOMG312491082281.9%2,655,695Unchanged
Guardant Health IncGHCOM40131M1092221.9%1,481,033Unchanged
Neurocrine Biosciences IncNBIXCOM64125C1092141.8%1,267,925Added+205,853
Tarsus Pharmaceuticals IncTARSCOM87650L1032111.8%3,357,059Added+11,034
Stoke Therapeutics IncSTOKCOM86150R1071841.6%5,623,525Unchanged
Uniqure NVSHSN900641011821.5%3,941,572Added+1,355,216
Acadia Pharmaceuticals IncACADCOM0042251081811.5%7,144,524Unchanged
Repligen CorpRGENCOM7599161091691.4%1,240,637Added+34,637
Urogen Pharma LtdCOMM960881051671.4%4,543,895Unchanged
GH Research plcORDINARY SHARESG3855L1061601.4%5,933,815Unchanged
Immunocore Holdings plcIMCRADS45258D1051551.3%4,869,798Unchanged
Compass Pathways plcCMPSSPONSORED ADS20451W1011511.3%10,700,974Added+68,584
Immatics N.VSHSN444451091311.1%12,946,176Added+76,836
ZAI Lab LtdZLABADR98887Q1041251.1%6,574,032Unchanged
Immunovant IncIMVTCOM45258J1021221.0%3,177,849Unchanged
Belite Bio IncBLTESPONSORED ADS07782B1041100.9%715,332Unchanged
Xencor IncXNCRCOM98401F1051090.9%6,777,461Unchanged
Taysha Gene Therapies IncTSHACOM SHS87761910692.30.8%13,560,258Reduced−119,990
Cogent Biosciences IncCOGTCOM19240Q20189.40.8%2,309,021Reduced−3,149,654
Alkermes plcSHSG0176710587.60.7%1,672,356Unchanged
Structure Therapeutics IncGPCRSPONSORED ADS86366E10686.30.7%1,607,507New+1,607,507
Replimune Group IncREPLCOM76029N10682.00.7%7,411,581Added+54,665
Castle Biosciences IncCSTLCOM14843C10566.30.6%2,778,335Added+20,000
Candel Therapeutics IncCADLCOM13740410966.10.6%6,422,018Unchanged
Rocket Pharmaceuticals IncRCKTCOM77313F10660.50.5%17,687,772Unchanged
Kodiak Sciences IncKODCOM50015M10958.00.5%1,487,934Unchanged
Aktis Oncology IncAKTSCOM01021M10451.30.4%1,592,043Unchanged
Axogen IncAXGNCOM05463X10646.70.4%1,011,576New+1,011,576
Danaher Corp DelDHRCOM23585110243.80.4%230,000New+230,000
Cullinan Therapeutics IncCGEMCOM23003110643.10.4%2,364,347Added+658,387
Neurogene IncNGNECOM64135M10542.80.4%1,362,456Unchanged
Hinge Health IncHNGECL A43331310341.50.4%500,000Reduced−1,430,000
Orchestra Biomed Holdings IncOBIOCOM68572M10641.20.4%9,556,063Added+1,250,000
Solid Biosciences IncSLDBCOM NEW83422E20438.90.3%3,892,926New+3,892,926
Savara IncSVRACOM80511110136.70.3%5,952,380Unchanged
Aquestive Therapeutics IncAQSTCOM03843E10430.90.3%7,426,471Unchanged
Kymera Therapeutics IncKYMRCOM50157510427.50.2%240,000Unchanged
Verastem IncVSTMCOM NEW92337C20325.30.2%6,635,793Added+59,487
Dianthus Therapeutics IncDNTHCOM25282810824.20.2%248,063Unchanged
Beta Bionics IncBBNXCOM08659B10223.50.2%1,500,000Reduced−500,000
Century Therapeutics IncIPSCCOM15673T10021.30.2%8,695,652Unchanged
Evommune IncEVMNCOM SHS30054Y10720.00.2%1,502,235Unchanged
Beam Therapeutics IncBEAMCOM07373V10519.60.2%570,394Unchanged
Definium Therapeutics IncDFTXCOM SHS24477V10518.80.2%400,000Added+100,000
Ideaya Biosciences IncIDYACOM45166A10213.80.1%370,370New+370,370
Ataibeckley IncCOM SHS04650F10110.5<0.1%2,000,000Unchanged
Milestone Pharmaceuticals inMISTCOM59935V10710.5<0.1%7,833,336Added+1,502,335
Ocugen IncOCGNCOM67577C10510.2<0.1%6,666,666Unchanged
Tenax Therapeutics IncTENXCOM NEW88032L60510.1<0.1%696,570Added+326,324
Heartflow IncHTFLCOM42238D1078.7<0.1%295,000Reduced−200,000
Perceptive Cap Solutions CorCL A ORD SHSG700771058.1<0.1%742,500Unchanged
Wave Life Sciences LtdSHSY953081057.8<0.1%1,350,000Unchanged
Larimar Therapeutics IncLRMRCOM5171251007.8<0.1%2,565,999Added+1,065,999
Lumexa Imaging Holdings IncLMRICOM5502491067.3<0.1%650,000Unchanged
Allogene Therapeutics IncALLOCOM0197701066.8<0.1%3,250,000New+3,250,000
Crescent Biopharma Inc.COMG2545C1046.7<0.1%372,856Unchanged
4D Molecular Therapeutics inFDMTCOM35104E1006.3<0.1%475,737Unchanged
Maze Therapeutics IncMAZECOM5787841006.3<0.1%212,000New+212,000
Capricor Therapeutics IncCAPRCOM NEW14070B3096.0<0.1%250,000Unchanged
Kalaris Therapeutics IncKLRSCOM4829291065.3<0.1%1,300,000Unchanged
Abivax SAABVXSPONSORED ADS00370M1033.5<0.1%26,400New+26,400
Avalo Therapeutics IncAVTXCOM NEW05338F3063.2<0.1%175,000Reduced−681,962
Medline IncMDLNCOM CL A58507V1072.8<0.1%70,000Unchanged
Disc Medicine IncIRONCOM2546041012.2<0.1%30,000Unchanged
Imagenebio IncIMACOM45175G2072.0<0.1%334,445Unchanged
Exagen IncXGNCOM30068X1030.9<0.1%195,000Reduced−200,231
Rocket Pharmaceuticals Inc*W EXP 09/02/20277313F1140.0<0.1%350,000Unchanged

Sold out: 13 positions

Held at the end of the quarter before and not reported this quarter.

RTW INVESTMENTS, LP, positions sold out
IssuerClassCUSIPReported value$WeightSharesPut or callChange on the quarter before
Apellis Pharmaceuticals IncCOM03753U1060.00.0%0Sold out−3,685,045
Apogee Therapeutics IncCOM03770N1010.00.0%0Sold out−2,782,097
Arrowhead Pharmaceuticals inARWRCOM04280A1000.00.0%0Sold out−585,682
Centessa Pharmaceuticals plcSPONSORED ADS1523091000.00.0%0Sold out−2,054,175
Compass Therapeutics IncCMPXCOM20454B1040.00.0%0Sold out−4,186,599
Crinetics Pharmaceuticals inCOM22663K1070.00.0%0Sold out−1,451,326
Fulgent Genetics IncFLGTCOM3596641090.00.0%0Sold out−1,289,000
Intuitive Surgical IncISRGCOM NEW46120E6020.00.0%0Sold out−220,000
Inventiva SAIVAADS46124U1070.00.0%0Sold out−1,298,702
Jade Biosciences IncJBIOCOM NEW0080642060.00.0%0Sold out−573,205
Omada Health IncOMDACOM68170A1080.00.0%0Sold out−200,000
Stryker CorporationSYKCOM8636671010.00.0%0Sold out−100,000
Waystar HLDG CorpWAYCOM9467841050.00.0%0Sold out−1,630,000

Source: SEC EDGAR, Form 13F-HR, accession 0001493215-26-000164 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.